NO960545D0 - Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin - Google Patents
Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobinInfo
- Publication number
- NO960545D0 NO960545D0 NO960545A NO960545A NO960545D0 NO 960545 D0 NO960545 D0 NO 960545D0 NO 960545 A NO960545 A NO 960545A NO 960545 A NO960545 A NO 960545A NO 960545 D0 NO960545 D0 NO 960545D0
- Authority
- NO
- Norway
- Prior art keywords
- administration
- treatment
- adverse effects
- effects associated
- extracellular hemoglobin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10613893A | 1993-08-13 | 1993-08-13 | |
PCT/IB1994/000239 WO1995005167A2 (en) | 1993-08-13 | 1994-08-09 | Treatment of adverse effects associated with administration of extracellular hemoglobin |
Publications (2)
Publication Number | Publication Date |
---|---|
NO960545D0 true NO960545D0 (no) | 1996-02-12 |
NO960545L NO960545L (no) | 1996-02-29 |
Family
ID=22309699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960545A NO960545L (no) | 1993-08-13 | 1996-02-12 | Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin |
Country Status (8)
Country | Link |
---|---|
US (1) | US5750132A (no) |
EP (2) | EP0784983A3 (no) |
JP (1) | JPH09501441A (no) |
AU (2) | AU7194694A (no) |
CA (1) | CA2167716A1 (no) |
IS (1) | IS4198A (no) |
NO (1) | NO960545L (no) |
WO (1) | WO1995005167A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995026195A1 (en) * | 1994-03-28 | 1995-10-05 | Baxter International Inc. | Therapeutic use of hemoglobin in the treatment of blood vessel blockage |
US6894150B1 (en) | 1999-10-01 | 2005-05-17 | Ross Walden Tye | Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin |
FR2809624B1 (fr) * | 2000-05-31 | 2002-08-02 | Centre Nat Rech Scient | Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve |
US7504377B2 (en) * | 2006-10-23 | 2009-03-17 | Ikor, Inc. | Nitric oxide-blocked cross-linked tetrameric hemoglobin |
US7494974B2 (en) * | 2006-10-24 | 2009-02-24 | Ikor, Inc. | Carboxymethylated cross-linked tetrameric hemoglobin |
EP2427483B1 (en) * | 2009-05-07 | 2015-03-11 | Hemarina | Novel heamoglobin and uses thereof |
WO2013036383A1 (en) * | 2011-09-06 | 2013-03-14 | Bing Lou Wong | Oral delivery for hemoglobin based oxygen carriers |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1579818A (en) * | 1977-06-07 | 1980-11-26 | Yamanouchi Pharma Co Ltd | Nifedipine-containing solid preparation composition |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US4529719A (en) * | 1983-05-04 | 1985-07-16 | Tye Ross W | Modified crosslinked stroma-free tetrameric hemoglobin |
US4965065A (en) * | 1986-04-29 | 1990-10-23 | Bristol-Myers Squibb Company | Gastroprotective process and compositions |
US5043358A (en) * | 1986-03-04 | 1991-08-27 | Bristol-Myers Squibb Company | Gastroprotective process |
US4826811A (en) * | 1986-06-20 | 1989-05-02 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
GB8711614D0 (en) * | 1987-05-16 | 1987-06-24 | Medical Res Council | Proteins |
EP0561245A1 (en) * | 1987-05-16 | 1993-09-22 | Somatogenetics International, Inc. | Blood substitutes comprising recombinant hemoglobin |
NL8901174A (nl) * | 1989-05-10 | 1990-12-03 | Het Hoofd Van De Afdeling Mili | Hemoglobine-preparaat en gebruik daarvan. |
US5545727A (en) * | 1989-05-10 | 1996-08-13 | Somatogen, Inc. | DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin |
US5173426A (en) * | 1989-10-06 | 1992-12-22 | Yale University | DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin |
US5478806A (en) * | 1989-11-22 | 1995-12-26 | Enzon, Inc. | Enhancement of antitumor therapy with hemoglobin-based conjugates |
CA2080589A1 (en) * | 1990-04-16 | 1991-10-17 | Joseph De Angelo | Expression of recombinant hemoglobin in yeast |
DE69132763D1 (de) * | 1990-12-20 | 2001-11-15 | Univ Alabama Res Foundation Bi | Transgenes, vernetztes hämoglobin |
AU2140492A (en) * | 1991-05-14 | 1992-12-30 | Biopure Corporation | Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents |
US5295944A (en) * | 1991-05-14 | 1994-03-22 | Dana-Farber Cancer Institute | Method for treating a tumor with ionizing radiation |
US5624823A (en) * | 1991-11-22 | 1997-04-29 | The General Hospital Corporation | DNA encoding procine interleukin-10 |
-
1994
- 1994-08-04 IS IS4198A patent/IS4198A/is unknown
- 1994-08-09 CA CA002167716A patent/CA2167716A1/en not_active Abandoned
- 1994-08-09 AU AU71946/94A patent/AU7194694A/en not_active Abandoned
- 1994-08-09 JP JP7506848A patent/JPH09501441A/ja active Pending
- 1994-08-09 WO PCT/IB1994/000239 patent/WO1995005167A2/en not_active Application Discontinuation
- 1994-08-09 EP EP97101811A patent/EP0784983A3/en not_active Withdrawn
- 1994-08-09 EP EP94921781A patent/EP0717619A1/en not_active Withdrawn
-
1995
- 1995-05-26 US US08/451,370 patent/US5750132A/en not_active Expired - Lifetime
-
1996
- 1996-02-12 NO NO960545A patent/NO960545L/no not_active Application Discontinuation
-
1998
- 1998-06-11 AU AU70110/98A patent/AU7011098A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0717619A1 (en) | 1996-06-26 |
EP0784983A3 (en) | 2001-03-21 |
WO1995005167A2 (en) | 1995-02-23 |
WO1995005167A3 (en) | 1995-04-13 |
AU7194694A (en) | 1995-03-14 |
IS4198A (is) | 1995-02-14 |
AU7011098A (en) | 1998-07-30 |
NO960545L (no) | 1996-02-29 |
US5750132A (en) | 1998-05-12 |
EP0784983A2 (en) | 1997-07-23 |
CA2167716A1 (en) | 1995-02-23 |
JPH09501441A (ja) | 1997-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV10878A (lv) | Adas apstradasana ar izveletiem amfifiliem kopolimeriem | |
NO912672L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer. | |
NO934304L (no) | Fremgangsmaate for behandling av fluoralumosilikatglass | |
NO910828D0 (no) | Preparat for behandling av erektil funksjonssvikt. | |
MX9205981A (es) | Administracion transdermica de melatonina. | |
IT1236831B (it) | Apparecchio per il trattamento dell'intestino in particolare per enteroclisma | |
BR9406209A (pt) | Derivados heterociclicos no tratamento de isquemia e doenças relacionadas | |
NO960173L (no) | Tri-substituerte imidazoler med multipel-terapeutiske egenskaper | |
CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
ZA872624B (en) | Medicament for the treatment of inflammations of the eye | |
NO914667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
EP0458641A3 (en) | Use of prostaglandin derivatives in the treatment of congestive heart failure | |
DE69309698D1 (de) | Hautbehandlung mit adhäsionsverstärkenden eigenschaften | |
DE69319639D1 (de) | Pulsmesser | |
DE69434777D1 (de) | Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln | |
NO960545D0 (no) | Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin | |
NO922521D0 (no) | Piperidinyletanolderivater med terapeutisk virkning | |
DE69122929D1 (de) | Pulsmessgerät | |
NO914071D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser | |
FI973185A0 (fi) | Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
IT1288399B1 (it) | Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi | |
KR930702990A (ko) | 섬유성 질병 치료제로서의 프로스타사이클린- 및 카르바사이클린 유도체 | |
IT1252659B (it) | Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano | |
GB9222012D0 (en) | Improvements relating to the treatment of haemophilia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |